FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18164911000001108: Raporsin XL 4mg tablets (Accord Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1705571000001110 Raporsin XL 4mg tablets (Accord Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1705581000001112 Raporsin XL 4mg tablets (Accord Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Is a Doxazosin 4mg modified-release tablets true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Is a Doxazosin 4mg m/r tablet false Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has active ingredient Doxazosin true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has specific active ingredient Doxazosin mesilate true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Is a Raporsin XL true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Has basis of strength substance Doxazosin true Inferred relationship Existential restriction modifier
Raporsin XL 4mg tablets (Accord Healthcare Ltd) Is a Doxazosin 4mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Raporsin XL 4mg tablets (Accord Healthcare Ltd) 28 tablet 2 x 14 tablets Has AMP True Raporsin XL 4mg tablets (Accord Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start